Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 21, 2015
Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysisTomoya Muto, Chikako Ohwada, Setsu Sawai, et al.
Urologic Oncology|May 18, 2010
The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumorsKenji Hashimoto, Hiroyuki Fujimoto, Tsutomu Kouno, et al.
Anticancer Research|April 30, 2022
Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab RegimenHiroaki Tanioka, Ken Shimada, Akihito Tsuji, et al.
The Lancet. Gastroenterology & Hepatology|May 13, 2017
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trialMasatoshi Kudo, Michihisa Moriguchi, Kazushi Numata, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 14, 2017
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)Yutaka Kimura, Masashi Fujii, Toshiki Masuishi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2014
Moving beyond the hazard ratio in quantifying the between-group difference in survival analysisHajime Uno, Brian Claggett, Lu Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 4, 2012
Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemiasShio Sakai, Chiaki Nakaseko, Masahiro Takeuchi, et al.
Internal Medicine (Tokyo, Japan)|July 23, 2019
Myeloid/Lymphoid Neoplasm with PDGFRB Rearrangement with t (5;10) (q33;q22) Harboring a Novel Breakpoint of the CCDC6-PDGFRB Fusion GeneMiki Yamazaki, Chiaki Nakaseko, Masahiro Takeuchi, et al.
Plos One|September 5, 2019
Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significanceAyako Nakamura, Chikako Ohwada, Masahiro Takeuchi, et al.
Oncotarget|July 26, 2018
Correction: A phase II trial of 1st-line modified-FOLFOXIRI plus bevacizumab treatment for metastatic colorectal cancer harboring RAS mutation: JACCRO CC-11Hironaga Satake, Yu Sunakawa, Yuji Miyamoto, et al.
Pageof 19